Home
Calliditas Therapeutics AB

Calliditas Therapeutics AB Market Share Analysis for April 2026

Calliditas Therapeutics AB är ett svenskt börsnoterat läkemedelsföretag, som utvecklar läkemedel för njur- och leversjukdomar, bland andra ett specialistläkemedel mot njursviktsjukdomen IgA-nefrit, som baseras på budesonid. Calliditas Therapeutics noterades på Stockholmsbörsen 2018 och på Nasdaq New York-börsen 2020.

Health > Biotechnology and Pharmaceuticals

Domaincalliditas.se

Year Founded2004

Employees51 - 200

Annual Revenue$100M - $200M

Calliditas Therapeutics AB

Calliditas Therapeutics AB (including company regionals)

calliditas.se

See more website traffic and engagement information

Calliditas Therapeutics AB Revenue up to April 2026 is 100M - 200M

revenue generated by Calliditas Therapeutics AB top domains

Calliditas Therapeutics AB top domains revenue over 3 years

Revenue for Calliditas Therapeutics AB top domains

calliditas.se100M - 200M

See more with Sales Intelligence

Total visits to Calliditas Therapeutics AB's top domains

Understand Calliditas Therapeutics AB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

calliditas.se4.3K

See more with Sales Intelligence

Avg. visit duration in Calliditas Therapeutics AB's top domains

Analyze Calliditas Therapeutics AB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

calliditas.se00:00:06

See more with Sales Intelligence

Avg. pageviews on Calliditas Therapeutics AB's top domains

See how Calliditas Therapeutics AB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

calliditas.se1.38

See more with Sales Intelligence

Calliditas Therapeutics AB top competitors by domain

Top similar sites in April 2026, ranked by their affinity

tscan.comCompany NameTScan Therapeutics, Inc.Employees51 - 200HQUnited States, Massachusetts, WalthamAnnual revenue$10M - $15MTotal visits5.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Calliditas Therapeutics AB

These are the website technologies, by industry, used by Calliditas Therapeutics AB top domains

Advertising (5)

DoubleClick

Social (3)

Instagram

Widget (3)

Twemoji

Conversion & Analytics (2)

Google Analytics

More Technologies

10

See all

News & Signals from Calliditas Therapeutics AB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCalliditas Therapeutics AB attends event World Congress of Nephrology.Calliditas Therapeutics to present biomarker analyses at World Congress of Nephrology.

NewsCalliditas Therapeutics AB launches product in the U.S. Prior.Under her leadership, Calliditas achieved the first-ever FDA approval for a treatment in IgA nephropathy (TARPEYO(R) and successfully launched the product in the U.S. Prior to her role at Calliditas, Ms. Aguiar-Lucander held various senior roles in the field of life sciences investment and corporate finance, including Partner and COO at Omega Fund Management and Managing Director at a global investment bank.

NewsCalliditas Therapeutics AB attended event 62nd European Renal Association Congress on Jun 9th '25.STOCKHOLM, June 9, 2025 /PRNewswire/ - Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data was presented at the 62nd European Renal Association Congress (ERA Congress), which took place in Vienna, Austria, from June 4 to 7.